Annual Cost Of Goods Sold
$8.20 B
+$248.00 M+3.12%
31 December 2023
Summary:
Teva Pharmaceutical Industries Limited annual cost of goods sold is currently $8.20 billion, with the most recent change of +$248.00 million (+3.12%) on 31 December 2023. During the last 3 years, it has fallen by -$733.00 million (-8.21%). TEVA annual cost of goods sold is now -27.03% below its all-time high of $11.24 billion, reached on 31 December 2017.TEVA Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$2.18 B
+$43.00 M+2.01%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited quarterly cost of goods sold is currently $2.18 billion, with the most recent change of +$43.00 million (+2.01%) on 30 September 2024. Over the past year, it has increased by +$184.00 million (+9.20%). TEVA quarterly cost of goods sold is now -34.01% below its all-time high of $3.31 billion, reached on 31 December 2016.TEVA Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$8.41 B
+$184.00 M+2.24%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited TTM cost of goods sold is currently $8.41 billion, with the most recent change of +$184.00 million (+2.24%) on 30 September 2024. Over the past year, it has increased by +$139.00 million (+1.68%). TEVA TTM cost of goods sold is now -29.61% below its all-time high of $11.95 billion, reached on 30 September 2017.TEVA TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TEVA Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.1% | +9.2% | +1.7% |
| 3 y3 years | -8.2% | +4.3% | -2.6% |
| 5 y5 years | -17.8% | -3.5% | -4.9% |
TEVA Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8.2% | +3.1% | at high | +13.6% | -2.6% | +6.6% |
| 5 y | 5 years | -17.8% | +3.1% | -13.0% | +13.6% | -10.0% | +6.6% |
| alltime | all time | -27.0% | >+9999.0% | -34.0% | +1699.7% | -29.6% | +4833.7% |
Teva Pharmaceutical Industries Limited Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.18 B(+2.0%) | $8.41 B(+2.2%) |
| June 2024 | - | $2.14 B(+4.5%) | $8.23 B(+0.7%) |
| Mar 2024 | - | $2.05 B(+0.3%) | $8.17 B(-0.4%) |
| Dec 2023 | $8.20 B(+3.1%) | $2.04 B(+2.1%) | $8.20 B(-0.9%) |
| Sept 2023 | - | $2.00 B(-4.0%) | $8.27 B(+0.9%) |
| June 2023 | - | $2.08 B(+0.1%) | $8.20 B(+1.1%) |
| Mar 2023 | - | $2.08 B(-1.6%) | $8.11 B(+2.0%) |
| Dec 2022 | $7.95 B(-4.0%) | $2.11 B(+9.7%) | $7.95 B(+0.8%) |
| Sept 2022 | - | $1.93 B(-3.3%) | $7.89 B(-2.1%) |
| June 2022 | - | $1.99 B(+3.7%) | $8.06 B(-0.6%) |
| Mar 2022 | - | $1.92 B(-6.3%) | $8.10 B(-2.2%) |
| Dec 2021 | $8.28 B(-7.3%) | $2.05 B(-2.1%) | $8.28 B(-4.1%) |
| Sept 2021 | - | $2.09 B(+2.7%) | $8.64 B(-0.4%) |
| June 2021 | - | $2.04 B(-3.2%) | $8.67 B(-0.8%) |
| Mar 2021 | - | $2.10 B(-12.5%) | $8.74 B(-2.1%) |
| Dec 2020 | $8.93 B(-4.5%) | $2.40 B(+13.1%) | $8.93 B(-1.2%) |
| Sept 2020 | - | $2.13 B(+0.9%) | $9.04 B(-1.5%) |
| June 2020 | - | $2.11 B(-8.2%) | $9.17 B(-1.9%) |
| Mar 2020 | - | $2.29 B(-8.6%) | $9.35 B(+0.0%) |
| Dec 2019 | $9.35 B(-6.3%) | $2.51 B(+10.9%) | $9.35 B(+5.7%) |
| Sept 2019 | - | $2.26 B(-0.9%) | $8.85 B(-3.2%) |
| June 2019 | - | $2.28 B(-0.4%) | $9.13 B(-4.0%) |
| Mar 2019 | - | $2.29 B(+14.4%) | $9.52 B(-4.6%) |
| Dec 2018 | $9.97 B(-11.2%) | $2.00 B(-21.4%) | $9.97 B(-5.6%) |
| Sept 2018 | - | $2.55 B(-4.3%) | $10.56 B(-3.8%) |
| June 2018 | - | $2.67 B(-3.0%) | $10.98 B(-1.8%) |
| Mar 2018 | - | $2.75 B(+6.0%) | $11.18 B(-0.5%) |
| Dec 2017 | $11.24 B(+9.6%) | $2.59 B(-12.6%) | $11.24 B(-6.0%) |
| Sept 2017 | - | $2.97 B(+3.6%) | $11.95 B(+1.7%) |
| June 2017 | - | $2.87 B(+1.9%) | $11.75 B(+6.4%) |
| Mar 2017 | - | $2.81 B(-15.0%) | $11.04 B(+7.7%) |
| Dec 2016 | $10.25 B(+23.6%) | $3.31 B(+19.8%) | $10.25 B(+14.2%) |
| Sept 2016 | - | $2.76 B(+27.8%) | $8.98 B(+8.6%) |
| June 2016 | - | $2.16 B(+7.0%) | $8.27 B(+1.2%) |
| Mar 2016 | - | $2.02 B(-0.7%) | $8.17 B(-1.5%) |
| Dec 2015 | $8.30 B(-10.0%) | $2.03 B(-0.9%) | $8.30 B(-2.9%) |
| Sept 2015 | - | $2.05 B(-0.6%) | $8.54 B(-2.3%) |
| June 2015 | - | $2.06 B(-3.8%) | $8.74 B(-3.5%) |
| Mar 2015 | - | $2.15 B(-5.8%) | $9.06 B(-1.7%) |
| Dec 2014 | $9.22 B(-4.1%) | $2.28 B(+1.3%) | $9.22 B(-2.7%) |
| Sept 2014 | - | $2.25 B(-5.7%) | $9.47 B(-1.9%) |
| June 2014 | - | $2.38 B(+3.5%) | $9.65 B(+0.6%) |
| Mar 2014 | - | $2.30 B(-9.1%) | $9.60 B(-0.1%) |
| Dec 2013 | $9.61 B(-0.6%) | $2.54 B(+4.4%) | $9.61 B(+0.8%) |
| Sept 2013 | - | $2.43 B(+4.2%) | $9.54 B(+0.6%) |
| June 2013 | - | $2.33 B(+0.9%) | $9.48 B(-0.1%) |
| Mar 2013 | - | $2.31 B(-6.2%) | $9.48 B(-1.9%) |
| Dec 2012 | $9.66 B(+9.9%) | $2.46 B(+3.9%) | $9.66 B(-3.3%) |
| Sept 2012 | - | $2.37 B(+1.5%) | $10.00 B(+2.8%) |
| June 2012 | - | $2.34 B(-6.3%) | $9.72 B(+3.5%) |
| Mar 2012 | - | $2.49 B(-10.8%) | $9.40 B(+6.8%) |
| Dec 2011 | $8.80 B(+24.7%) | $2.79 B(+33.2%) | $8.80 B(+10.6%) |
| Sept 2011 | - | $2.10 B(+4.3%) | $7.96 B(+4.1%) |
| June 2011 | - | $2.01 B(+6.3%) | $7.64 B(+4.6%) |
| Mar 2011 | - | $1.89 B(-3.2%) | $7.31 B(+3.6%) |
| Dec 2010 | $7.06 B(+8.0%) | $1.95 B(+9.6%) | $7.06 B(+3.7%) |
| Sept 2010 | - | $1.78 B(+6.2%) | $6.80 B(+2.4%) |
| June 2010 | - | $1.68 B(+2.4%) | $6.64 B(+0.7%) |
| Mar 2010 | - | $1.64 B(-3.7%) | $6.60 B(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $6.53 B(+27.7%) | $1.70 B(+5.0%) | $6.53 B(+7.5%) |
| Sept 2009 | - | $1.62 B(-0.6%) | $6.08 B(+4.7%) |
| June 2009 | - | $1.63 B(+3.5%) | $5.81 B(+5.7%) |
| Mar 2009 | - | $1.58 B(+26.2%) | $5.49 B(+7.3%) |
| Dec 2008 | $5.12 B(+12.9%) | $1.25 B(-7.5%) | $5.12 B(+0.4%) |
| Sept 2008 | - | $1.35 B(+2.4%) | $5.10 B(+4.8%) |
| June 2008 | - | $1.32 B(+9.8%) | $4.86 B(+3.7%) |
| Mar 2008 | - | $1.20 B(-2.4%) | $4.69 B(+3.5%) |
| Dec 2007 | $4.53 B(+9.2%) | $1.23 B(+10.1%) | $4.53 B(+1.2%) |
| Sept 2007 | - | $1.12 B(-2.4%) | $4.48 B(+2.1%) |
| June 2007 | - | $1.14 B(+9.6%) | $4.38 B(+3.3%) |
| Mar 2007 | - | $1.04 B(-11.2%) | $4.24 B(+2.3%) |
| Dec 2006 | $4.15 B(+49.8%) | $1.17 B(+14.7%) | $4.15 B(+12.2%) |
| Sept 2006 | - | $1.02 B(+2.3%) | $3.70 B(+9.6%) |
| June 2006 | - | $1.00 B(+5.5%) | $3.37 B(+11.8%) |
| Mar 2006 | - | $949.00 M(+31.0%) | $3.02 B(+8.9%) |
| Dec 2005 | $2.77 B(+8.2%) | $724.70 M(+3.7%) | $2.77 B(+0.6%) |
| Sept 2005 | - | $698.70 M(+8.3%) | $2.75 B(+1.5%) |
| June 2005 | - | $645.40 M(-8.0%) | $2.71 B(+0.8%) |
| Mar 2005 | - | $701.20 M(-0.8%) | $2.69 B(+5.0%) |
| Dec 2004 | $2.56 B(+45.7%) | $707.20 M(+7.5%) | $2.56 B(+8.4%) |
| Sept 2004 | - | $657.70 M(+5.6%) | $2.36 B(+10.4%) |
| June 2004 | - | $623.10 M(+8.9%) | $2.14 B(+11.4%) |
| Mar 2004 | - | $572.00 M(+12.4%) | $1.92 B(+9.3%) |
| Dec 2003 | $1.76 B(+23.5%) | $509.00 M(+16.9%) | $1.76 B(+4.6%) |
| Sept 2003 | - | $435.40 M(+7.7%) | $1.68 B(+4.7%) |
| June 2003 | - | $404.10 M(-1.2%) | $1.60 B(+5.2%) |
| Mar 2003 | - | $409.00 M(-5.1%) | $1.53 B(+7.2%) |
| Dec 2002 | $1.42 B(+15.7%) | $431.00 M(+19.5%) | $1.42 B(+7.9%) |
| Sept 2002 | - | $360.70 M(+11.0%) | $1.32 B(+4.8%) |
| June 2002 | - | $324.90 M(+6.0%) | $1.26 B(+1.3%) |
| Mar 2002 | - | $306.60 M(-6.3%) | $1.24 B(+1.0%) |
| Dec 2001 | $1.23 B(+27.7%) | $327.18 M(+9.1%) | $1.23 B(+9.8%) |
| Sept 2001 | - | $300.00 M(-2.9%) | $1.12 B(+2.8%) |
| June 2001 | - | $308.85 M(+5.1%) | $1.09 B(+5.6%) |
| Mar 2001 | - | $293.96 M(+35.0%) | $1.03 B(+10.0%) |
| Dec 2000 | $962.99 M(+37.7%) | $217.80 M(-19.3%) | $938.37 M(+6.7%) |
| Sept 2000 | - | $269.72 M(+7.4%) | $879.38 M(+9.6%) |
| June 2000 | - | $251.10 M(+25.7%) | $802.36 M(+10.8%) |
| Mar 2000 | - | $199.75 M(+25.8%) | $724.15 M(+3.6%) |
| Dec 1999 | $699.20 M(+9.9%) | $158.80 M(-17.6%) | $699.20 M(+5.7%) |
| Sept 1999 | - | $192.70 M(+11.5%) | $661.70 M(+1.0%) |
| June 1999 | - | $172.90 M(-1.1%) | $655.00 M(+2.3%) |
| Mar 1999 | - | $174.80 M(+44.1%) | $640.50 M(+0.7%) |
| Dec 1998 | $636.10 M(+1.1%) | $121.30 M(-34.8%) | $636.20 M(+23.6%) |
| Sept 1998 | - | $186.00 M(+17.4%) | $514.90 M(+56.6%) |
| June 1998 | - | $158.40 M(-7.1%) | $328.90 M(+92.9%) |
| Mar 1998 | - | $170.50 M | $170.50 M |
| Dec 1997 | $628.90 M(+14.3%) | - | - |
| Dec 1996 | $550.40 M(+14.3%) | - | - |
| Dec 1995 | $481.50 M(+15.7%) | - | - |
| Dec 1994 | $416.20 M(+55.0%) | - | - |
| Dec 1993 | $268.50 M(+20.0%) | - | - |
| Dec 1992 | $223.80 M(+15.3%) | - | - |
| Dec 1991 | $194.10 M(+1.5%) | - | - |
| Dec 1990 | $191.30 M(+5.9%) | - | - |
| Dec 1989 | $180.70 M(+39.5%) | - | - |
| Dec 1988 | $129.50 M(+52.5%) | - | - |
| Mar 1987 | $84.90 M(+44.4%) | - | - |
| Mar 1986 | $58.80 M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual cost of goods sold?
- What is the all time high annual cost of goods sold for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual cost of goods sold year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM cost of goods sold year-on-year change?
What is Teva Pharmaceutical Industries Limited annual cost of goods sold?
The current annual cost of goods sold of TEVA is $8.20 B
What is the all time high annual cost of goods sold for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual cost of goods sold is $11.24 B
What is Teva Pharmaceutical Industries Limited annual cost of goods sold year-on-year change?
Over the past year, TEVA annual cost of goods sold has changed by +$248.00 M (+3.12%)
What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold?
The current quarterly cost of goods sold of TEVA is $2.18 B
What is the all time high quarterly cost of goods sold for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly cost of goods sold is $3.31 B
What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold year-on-year change?
Over the past year, TEVA quarterly cost of goods sold has changed by +$184.00 M (+9.20%)
What is Teva Pharmaceutical Industries Limited TTM cost of goods sold?
The current TTM cost of goods sold of TEVA is $8.41 B
What is the all time high TTM cost of goods sold for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM cost of goods sold is $11.95 B
What is Teva Pharmaceutical Industries Limited TTM cost of goods sold year-on-year change?
Over the past year, TEVA TTM cost of goods sold has changed by +$139.00 M (+1.68%)